PCG Digital: Lexaria DehydraTECH 2.0 Outperforms MCT in 2021 R&D Study
PCG Digital: Lexaria DehydraTECH 2.0 Outperforms MCT in 2021 R&D Study New York, New York--(Newsfile Corp. - May 25, 2021) - PCG Digital -- The positive results keep rolling in for Lexaria (LEXX). They recently released R&D study results for three new DehydraTECH TM 2.0 formulation variations that significantly outperformed traditional MCT oil-based formulations that have become CBD industry standard. Though new to NASDAQ, Lexaria Bioscience Corp. has been producing positive test results with their patented DehydraTECH TM bio-absorption technology since 2016. The process has been used in foo...
Source: finanznachrichten.de